| 1 |
Jung M, Ahn JB, Chang JH, et al. Brain metastases from colorectal carcinoma: prognostic factors and outcome [J]. J Neurooncol, 2011, 101(1): 49-55.
|
| 2 |
Akil H, Perraud A, Jauberteau MO, et al. Tropomyosin-related kinase B/brain derived-neurotrophic factor signaling pathway as a potential therapeutic target for colorectal cancer [J]. World J Gastroenterol, 2016, 22(2): 490-500.
|
| 3 |
Lu X, Cai Y, Xia L, et al. Treatment modalities and relative survival in patients with brain metastasis from colorectal cancer [J]. Biosci Trends, 2019, 13(2): 182-188.
|
| 4 |
Luo D, Liu Q, Yu W, et al. Prognostic value of distant metastasis sites and surgery in stage IV colorectal cancer: a population-based study [J]. Int J Colorectal Dis, 2018, 33(9): 1241-1249.
|
| 5 |
Tapia Rico G, Price TJ, Karapetis C, et al. Brain metastasis in advanced colorectal cancer: results from the South Australian metastatic colorectal cancer (SAmCRC) registry [J]. Cancer Biol Med, 2017, 14(4): 371-376.
|
| 6 |
Shibahara I, Kanamori M, Watanabe T, et al. Clinical features of precocious, synchronous, and metachronous brain metastases and the role of tumor resection[J]. World Neurosurg, 2018, 113: e1-e9.
|
| 7 |
Quan JC, Guan X, Ma CX, et al. Prognostic scoring system for synchronous brain metastasis at diagnosis of colorectal cancer: A population-based study[J]. World J Gastrointest Oncol, 2020, 12(2): 195-204.
|
| 8 |
Chyun Y, Hayward E, Lokich J. Metastasis to the central nervous system from colorectal cancer[J]. Medical and Pediatric Oncology, 1980, 8(3): 305-308.
|
| 9 |
Hassan SM, Mubarik A, Muddassir S, et al. Brain metastasis in colorectal cancer presenting as refractory hypertension [J]. J Community Hosp Intern Med Perspect, 2018, 8(4): 215-219.
|
| 10 |
Mongan JP, Fadul CE, Cole BF, et al. Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines[J]. Clin Colorectal Cancer, 2009, 8(2): 100-105.
|
| 11 |
Lee WLA, Michael-Titus AT, Shah DK. Hypoxic-ischaemic encephalopathy and the blood-brain barrier in neonates [J]. Developmental Neuroscience, 2017, 39(1-4): 49-58.
|
| 12 |
Abbott NJ. Blood-brain barrier structure and function and the challenges for CNS drug delivery [J]. Journal of Inherited Metabolic Disease, 2013, 36(3): 437-449.
|
| 13 |
Engelhardt B, Liebner S. Novel insights into the development and maintenance of the blood-brain barrier [J]. Cell and Tissue Research, 2014, 355(3): 687-699.
URL
|
| 14 |
Adkins CE, Mohammad AS, Terrell-Hall TB, et al. Characterization of passive permeability at the blood-tumor barrier in five preclinical models of brain metastases of breast cancer [J]. Clinical & Experimental Metastasis, 2016, 33(4): 373-383.
|
| 15 |
Percy DB, Ribot EJ, Chen Y, et al. In vivo characterization of changing blood-tumor barrier permeability in a mouse model of breast cancer metastasis: a complementary magnetic resonance imaging approach[J]. Investigative Radiology, 2011, 46(11): 718-725.
URL
|
| 16 |
Tie J, Lipton L, Desai J, et al. KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer [J]. Clinical Cancer Research: an Official Journal of the American Association for Cancer Research, 2011, 17(5): 1122-1130.
URL
|
| 17 |
Aprile G, Casagrande M, De Maglio G, et al. Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors [J]. Future Oncol, 2017, 13(2): 135-144.
|
| 18 |
Kim J, Takeuchi H, Lam ST, et al. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival [J]. J Clin Oncol, 2005, 23(12): 2744-2753.
|
| 19 |
Zang YW, Gu XD, Xiang JB, et al. Brain metastases from colorectal cancer: microenvironment and molecular mechanisms[J]. Int J Mol Sci, 2012, 13(12): 15784-15800.
|
| 20 |
Zaytseva YY, Rychahou PG, Gulhati P, et al. Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer [J]. Cancer research, 2012, 72(6): 1504-1517.
URL
|
| 21 |
Hotary K, Li XY, Allen E, et al. A cancer cell metalloprotease triad regulates the basement membrane transmigration program [J]. Genes & Development, 2006, 20(19): 2673-2686.
|
| 22 |
Kim DY, Ryu CG, Jung EJ, et al. Brain metastasis from colorectal cancer: a single center experience [J]. Ann Surg Treat Res, 2018, 94(1): 13-18.
|
| 23 |
Chu C, Navalkissoor S, Gillmore R. Neurological symptoms from a brain metastasis as the first presentation of colorectal cancer[J]. BMJ Case Rep, 2015, 2015: bcr2015210422.
|
| 24 |
Lei S, Ge Y, Tian S, et al. Colorectal cancer metastases to brain or bone and the relationship to primary tumor location: a population-based study [J]. J Gastrointest Surg, 2019, 24: 1833-1842.
|
| 25 |
Suzuki Y, Yamaguchi T, Matsumoto H, et al. Prognostic factors and treatment effects in patients with curatively resected brain metastasis from colorectal cancer [J]. Diseases of the Colon and Rectum, 2014, 57(1): 56-63.
URL
|
| 26 |
Imaizumi J, Shida D, Narita Y, et al. Prognostic factors of brain metastases from colorectal cancer [J]. BMC Cancer, 2019, 19(1): 755.
|
| 27 |
Prabhu RS, Press RH, Patel KR, et al. Single-fraction stereotactic radiosurgery (SRS) alone versus surgical resection and SRS for large brain metastases: a multi-institutional analysis[J]. International Journal of Radiation Oncology, Biology, Physics, 2017, 99(2): 459-467.
|
| 28 |
Esmaeilzadeh M, Majlesara A, Faridar A, et al. Brain metastasis from gastrointestinal cancers: a systematic review [J]. Int J Clin Pract, 2014, 68(7): 890-899.
|
| 29 |
Paix A, Antoni D, Adeduntan R, et al. Stereotactic radiation therapy of brain metastases from colorectal cancer: A single institution cohort [J]. Cancer Radiother, 2017, 21(3): 199-204.
|
| 30 |
Mahajan A, Ahmed S, Mcaleer MF, et al. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial [J]. Lancet Oncol, 2017, 18(8): 1040-1048.
|
| 31 |
Brown PD, Ballman KV, Cerhan JH, et al. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC•3): a multicentre, randomised, controlled, phase 3 trial [J]. Lancet Oncol, 2017, 18(8): 1049-1060.
|
| 32 |
Shi S, Sandhu N, Jin MC, et al. Stereotactic radiosurgery for resected brain metastases: single-institutional experience of over 500 cavities [J]. International Journal of Radiation Oncology, Biology, Physics, 2020, 106(4): 764-771.
|
| 33 |
Finkelmeier F, You SJ, Waidmann O, et al. Bevacizumab in combination with chemotherapy for colorectal brain metastasis[J]. J Gastrointest Cancer, 2016, 47(1): 82-88.
|
| 34 |
中国医师协会结直肠肿瘤专业委员会. 中国结直肠癌脑转移多学科综合治疗专家共识(2020版) [J/CD]. 中华结直肠疾病电子杂志, 2020, 9(2): 109-114.
|
| 35 |
Colorectal Cancer Committee of Chinese Medical Doctor Association.Guideline and Consensus Chinese experts consensus on multidisciplinary treatment of brain metastases from colorectal cancer (2020 version) [J/CD]. Chin J Colorec Dis (Electronic Edition), 2020, 9(2): 109-114.
|
| 36 |
中国医师协会结直肠肿瘤专业委员会. 中国结直肠癌脑转移多学科综合治疗专家共识(2020版) [J/CD]. 中华结直肠疾病电子杂志, 2020, 9(2): 109-114.
|
| 37 |
Arneson K, Mondschein J, Stavas M, et al. A phase I trial of concurrent sorafenib and stereotactic radiosurgery for patients with brain metastases [J]. J Neurooncol, 2017, 133(2): 435-442.
|
| 38 |
Noura S, Ohue M, Shingai T, et al. Brain metastasis from colorectal cancer: prognostic factors and survival [J]. J Surg Oncol, 2012, 106(2): 144-148.
URL
|
| 39 |
Kye BH, Kim HJ, Kang WK, et al. Brain metastases from colorectal cancer: the role of surgical resection in selected patients [J]. Colorectal Disease: the Official Journal of the Association of Coloproctology of Great Britain and Ireland, 2012, 14(7): e378-e85.
|
| 40 |
Patel AR, Nedzi L, Lau S, et al. Neoadjuvant stereotactic radiosurgery before surgical resection of cerebral metastases [J]. World Neurosurg, 2018, 120: e480-e487.
|
| 41 |
Tokoro T, Okuno K, Hida J C, et al. Prognostic factors for patients with advanced colorectal cancer and symptomatic brain metastases [J]. Clin Colorectal Cancer, 2014, 13(4): 226-231.
|
| 42 |
Quan J, Ma C, Sun P, et al. Brain metastasis from colorectal cancer: clinical characteristics, timing, survival and prognostic factors [J]. Scand J Gastroenterol, 2019, 54(11): 1370-1375.
|
| 43 |
Christensen TD, Palshof JA, Larsen FO, et al. Risk factors for brain metastases in patients with metastatic colorectal cancer [J]. Acta Oncologica (Stockholm, Sweden), 2017, 56(5): 639-645.
|
| 44 |
Gu XD, Cai YT, Zhou YM, et al. Prognostic factors and multidisciplinary treatment modalities for brain metastases from colorectal cancer: analysis of 93 patients [J]. BMC Cancer, 2015, 15: 902.
|